BRIEF published on 10/24/2024 at 17:50, 27 days 17 hours ago Cegedim: Steady Revenue Growth in Q3 2024 Driven by Key Sectors Revenue Growth Cloud Services Q3 2024 Data & Marketing BPO Performance
REGULATED PRESS RELEASE published on 10/24/2024 at 17:45, 27 days 17 hours ago Cegedim: Revenue growth continued in the third quarter of 2024 Cegedim's Q3 2024 revenue grows 5.7%, led by Marketing, BPO, HR, and cloud businesses. Total revenue for 9M2024 increases by 5.9% to €475.8 million. Quarterly financial breakdown provided Financial Information Revenue Growth Q3 2024 Cegedim Business Trends
BRIEF published on 10/10/2024 at 08:35, 1 month 11 days ago Strategic partnership between Cegedim and PHAST to improve the traceability of medical devices Interoperability Strategic Partnership Digital Health DMI Traceability Hospital Management
BRIEF published on 10/03/2024 at 08:35, 1 month 18 days ago Strategic partnership between Claude Bernard and Medipim Strategic Partnership Claude Bernard Medipim Health Products Single API
BRIEF published on 09/18/2024 at 08:35, 2 months 3 days ago Cegedim Assurances obtains a new certification: ISO 22301 Certification Résilience Business Continuity ISO 22301 Cegedim Insurance
BRIEF published on 07/31/2024 at 17:50, 3 months 20 days ago Cegedim Secures €230 Million Financing Arrangement Credit Facility Syndicated Loan Debt Refinancing Financing Arrangement Cegedim
PRESS RELEASE published on 07/31/2024 at 17:45, 3 months 20 days ago Cegedim: New €230 million financing arrangement Cegedim secures new €230 million financing arrangement, comprising a €180 million refinancing loan and a €50 million revolving credit facility, enhancing liquidity and extending debt maturity Revolving Credit Facility Financing Arrangement Cegedim €230 Million Refinancing Loan
BRIEF published on 05/14/2024 at 08:35, 6 months 7 days ago Claude Bernard launches a new web component portal for healthcare publishers Interoperability Software Integration Web Portal Database Health Edition
PRESS RELEASE published on 03/27/2024 at 17:45, 7 months 24 days ago Cegedim Full year 2023 results: Revenue and recurring operating income both up
PRESS RELEASE published on 07/04/2023 at 18:40, 1 year 4 months ago Cegedim: Half-year liquidity contract statement
Published on 11/21/2024 at 10:03, 57 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 25 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 35 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:56, 3 minutes ago ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 30 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 55 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 58 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 1 hour ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 06:58, 4 hours 2 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 40 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 15 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 15 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
